American Journal of Ophthalmology
Volume 142, Issue 3 , Pages 419-428.e1 , September 2006

Risk Factors for Five-Year Incident Age-related Macular Degeneration: The Reykjavik Eye Study

  • Arsaell Arnarsson, MSc

      Affiliations

    • Department of Ophthalmology, University of Iceland, Reykjavik, Iceland
  • ,
  • Thordur Sverrisson, MD

      Affiliations

    • Department of Ophthalmology, University of Iceland, Reykjavik, Iceland
    • Kanazawa Medical University, Uchinada, Japan.
  • ,
  • Einar Stefánsson, MD

      Affiliations

    • Department of Ophthalmology, University of Iceland, Reykjavik, Iceland
  • ,
  • Haraldur Sigurdsson, MD

      Affiliations

    • Department of Ophthalmology, University of Iceland, Reykjavik, Iceland
  • ,
  • Hiroshi Sasaki, MD

      Affiliations

    • Kanazawa Medical University, Uchinada, Japan.
  • ,
  • Kazuyuki Sasaki, MD

      Affiliations

    • Kanazawa Medical University, Uchinada, Japan.
  • ,
  • Fridbert Jonasson, MD

      Affiliations

    • Department of Ophthalmology, University of Iceland, Reykjavik, Iceland
    • Corresponding Author InformationInquiries to Fridbert Jonasson, MD, Department of Ophthalmology, University of Iceland, Landspitalinn, 101 Reykjavik, Iceland

,Accepted 1 April 2006.

References 

  1. Hyman L , Schachat AP , He Q , Leske MC  Age-Related Macular Degeneration Risk Factor Study Group . Hypertension, cardiovascular disease, and age-related macular degeneration . Arch Ophthalmol . 2000;118:351–358
  2. Jonasson F , Thordarson K . Prevalence of ocular disease and blindness in a rural area in the eastern region of Iceland during 1980 through 1984 . Acta Ophthalmol . 1987;182:S40–S43
  3. Buch H , Nielsen NV , Vinding T , Jensen GB , Prause JU , La Cour M . 14-year incidence, progression and visual morbidity of age-related maculopathy (the Copenhagen City Eye Study) . Ophthalmology . 2005;112:787–798
  4. Klein R , Klein BEK , Jensen SC , Meuer SM . The five-year incidence and progression of age-related maculopathy (the Beaver Dam Study) . Ophthalmology . 1997;104:7–21
  5. Klaver CC , Assink JJ , van Leeuwen R , et al.   Incidence and progression rates on age-related maculopathy (the Rotterdam Study) . Invest Ophthalmol Vis Sci . 2001;42:2237–2241
  6. Wang JJ , Foran S , Smith W , Mitchell P . Risk of age-related macular degeneration in eyes with macular drusen or hyperpigmentation (the Blue Mountains Eye Study Cohort) . Arch Ophthalmol . 2003;121:658–663
  7. Jonasson F , Arnarsson A , Peto T , Sasaki H , Sasaki K , Bird AC . The prevalence of age-related maculopathy in Iceland (the Reykjavik Eye Study) . Arch Ophthalmol . 2003;121:379–385
  8. Jonasson F , Arnarsson A , Peto T , Sasaki H , Sasaki K , Bird AC . Five-year incidence of age-related maculopathy in the Reykjavik Eye Study . Ophthalmology . 2005;112:132–138
  9. Holz FG , Wolfensberger TJ , Piguet B , et al.   Bilateral macular drusen in age-related macular degeneration (prognosis and risk factors) . Ophthalmology . 1994;101:1522–1528
  10. van Leeuwen R , Klaver CC , Vingerling JR , et al.   The risk and natural course age-related maculopathy (follow up at 6½ years in the Rotterdam Study) . Arch Ophthalmol . 2003;121:519–526
  11. Klein R , Wang Q , Klein BE , et al.   The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity . Invest Ophthalmol Vis Sci . 1995;36:182–191
  12. Sunness JS , Gonzalez-Baron J , Applegate CA , et al.   Enlargement of atrophy and visual acuity loss in the geographic atrophy form of age-related macular degeneration . Ophthalmology . 1993;106:1768–1779
  13. Tomany SC , Wang JJ , van Leeuwen R , et al.   Risk factors for incident age-related macular degeneration (pooled findings from three continents) . Ophthalmology . 2004;111:1280–1287
  14. Age-Related Eye Disease Study Group . Risk factors for the incidence of advanced age-related macular degeneration in the Age-Related Eye Disease Study (AREDS). AREDS Report 19 . Ophthalmology . 2005;112:533–539
  15. Khan JC , Thurlby DA , Sahid H , et al.   Smoking and age-related macular degeneration (the number of pack-years of cigarette smoking is a major determinant for risk of both geographic atrophy and choroidal neovascularization) . Br J Ophthalmol . 2006;90:75–80
  16. Evans JR , Fletcher AE , Wormald RL . Age-related macular degeneration causing visual impairment in people 75 years or older in Britain . Ophthalmology . 2004;11:513–517
  17. Edwards AO, Ritter R III, Abel KJ, et al. Complement factor H polymorphism and age-related macular degeneration. Science 308:421–424.
  18. Haines JL , Hauser MA , Schmidt S , et al.   Complement factor H variant increases the risk of age-related macular degeneration . Science . 2005;308:419–421
  19. Klein RJ , Zeiss C , Chew EY , et al.   Complement factor H polymorphism in age-related macular degeneration . Science . 2005;308:385–389
  20. Hageman GS , Anderson DH , Johnson LV , et al.   A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration . Proc Natl Acad Sci U S A . 2005;102:7227–7232
  21. Magnusson KP , Duan S , Sigurdsson H , et al.   CFH Y402H confers similar risk of soft drusen and both forms of advanced AMD . PLoS Med . 2006;3:109–114
  22. Sasaki H , Jonasson F , Kojima M , et al.   The Reykjavik Eye Study (prevalence of lens opacification with reference to identical Japanese studies) . Ophthalmologica . 2000;214:412–420
  23. Jonasson F , Damji KF , Arnarsson A , et al.   Prevalence of open-angle glaucoma in Iceland (Reykjavik Eye Study) . Eye . 2003;17:747–753
  24. Katoh N , Jonasson F , Sasaki H , et al.   Cortical lens opacification in Iceland (risk factor analysis—Reykjavik Eye Study) . Acta Ophthalmol Scand . 2001;79:154–159
  25. Bird AC , Bressler NM , Bressler SB , et al.  International ARM Epidemiological Study Group   An international classification and grading system for age-related maculopathy and age-related macular degeneration . Surv Ophthalmol . 1995;39:367–374
  26. Klein R , Davis MD , Magli YL , et al.   The Wisconsin age-related maculopathy grading system . Ophthalmology . 1991;98:1128–1134
  27. Chaine G , Hullo A , Sahel J , et al.   Case-control study of the risk factors for age-related macular degeneration . Br J Ophthalmol . 1998;82:996–1002
  28. Hirvelä H , Luukinen H , Läärä E , Laatikainen L . Risk factors of age-related maculopathy in a population 70 years of age or older . Ophthalmology . 1996;103:871–877
  29. Pauleikhoff D , Wormald RP , Wright L , Wessing A , Bird AC . Macular disease in an elderly population . Geriatr J Ophthalmol . 1992;1:12–15
  30. West SK , Rosenthal FS , Bressler NM , et al.   Exposure to sunlight and other risk factors for age-related macular degeneration . Arch Ophthalmol . 1989;107:875–879
  31. Buch H , Vinding T , la Cour M , Jensen GB , Prause JU , Nielsen NV . Risk factors for age-related maculopathy in a 14-year follow-up study (the Copenhagen City Eye Study) . Acta Ophthalmol Scand . 2005;83:409–418
  32. Klein R , Klein BEK , Jensen SC , Moss SE . The relationship of socioeconomic factors to the incidence of early age-related maculopathy (the Beaver Dam Eye Study) . Am J Ophthalmol . 2001;132:128–131
  33. VandenLangenberg GM , Mares-Perlman JA , Klein R , Klein BEK , Brady WE , Palta M . Associations between antioxidant and zinc intake and the five-year incidence of early age-related maculopathy in the Beaver Dam Eye Study . Am J Epidemiol . 1998;148:204–214
  34. Agarwal S , Rao AV . Tomato lycopene and its role in human health and chronic diseases . CMAJ . 2000;163:739–744
  35. Klein R , Klein BE , Jensen SC , Cruickshanks KJ . The relationship of ocular factors to the incidence and progression of age-related maculopathy . Arch Ophthalmol . 1998;116:506–513
  36. Klein R , Klein BE , Wong TY , et al.   The association of cataract and cataract surgery with the long-term incidence of age-related maculopathy (the Beaver Dam Eye Study) . Arch Ophthalmol . 2002;120:1551–1558
  37. Wang JJ , Klein R , Smith W , et al.   Cataract surgery and the five-year incidence of late-stage age-related maculopathy (pooled findings from the Beaver Dam and Blue Mountains Eye Studies) . Ophthalmology . 2003;110:1960–1967
  38. van Leeuwen R , Ikram K , Vingerling JR , Witteman JCM , Hofman A , de Jong PTVM . Blood pressure, atherosclerosis, and the incidence of age-related maculopathy (the Rotterdam Study) . Invest Ophthalmol Vis Sci . 2003;44:3771–3777
  39. Klein R , Klein BEK , Tomany SC , Cruickshanks KJ . The association of cardiovascular disease with the long-term incidence of age-related maculopathy (the Beaver Dam Eye Study) . Ophthalmology . 2002;110:636–643
  40. Smith W , Mitchell P , Leeder SR , Wang JJ . Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy (the Blue Mountains Eye Study) . Arch Ophthalmol . 1998;116:583–587
  41. Hyman LG , Lilienfeld AM , Ferris FL , Fine SL . Senile macular degeneration (a case-control study) . Am J Epidemiol . 1983;118:213–227
  42. Klein BEK , Klein R , Lee KE . Reproductive exposures, incident age-related cataracts, and age-related maculopathy in women (the Beaver Dam Eye Study) . Am J Ophthalmol . 2000;130:322–326
  43. Smith W , Mitchell P , Leeder SR . Dietary fat and fish intake and age-related maculopathy . Arch Ophthalmol . 2000;118:401–404
  44. Seddon JM , Cote J , Rosner B . Progression of age-related macular degeneration. Association with dietary fat, transunsaturated fat, nuts, and fish intake . Arch Ophthalmol . 2003;121:1728–1737
  45. FAO Fisheries Statistics 1986. Commodities 63 . Rome, Italy: Food and Agriculture Organization of the United Nations; 1988;

 Supplemental Material available at AJO.com.Supported in part by open Grants (all to F.J.) from St Joseph’s Hospital, Landakot Foundation, Reykjavik, Iceland; University National Hospital and University of Iceland Research Grant; and Helga Jonsdottir and Sigurlidi Kristjansson Memorial Research Fund.

PII: S0002-9394(06)00477-6

doi: 10.1016/j.ajo.2006.04.015

American Journal of Ophthalmology
Volume 142, Issue 3 , Pages 419-428.e1 , September 2006